Therapeutic targets in cancer treatment: Cell cycle proteins

Adv Protein Chem Struct Biol. 2023:135:313-342. doi: 10.1016/bs.apcsb.2023.02.003. Epub 2023 Mar 8.

Abstract

Cancer has been linked to the uncontrolled proliferation of cells and the overexpression of cell-cycle genes. The cell cycle machinery plays a crucial role in the regulation of the apoptosis to mitosis to growth phase progression. The mechanisms of the cell cycle also play an important role in preventing DNA damage. There are multiple members of the protein kinase family that are involved in the activities of the cell cycle. Essential cyclins effectively regulate cyclin-dependent kinases (CDKs), which are themselves adversely regulated by naturally occurring CDK inhibitors. Despite the fact that various compounds can effectively block the cell cycle kinases and being investigated for their potential to fight cancer. This chapter explains the detail of cell cycle and checkpoint regulators, that are crucial to the malignant cellular process. The known CDKs inhibitors and their mechanism of action in various cancers have also been addressed as a step toward the development of a possibly novel technique for the design of new drugs against cell cycle kinase proteins.

Keywords: CDKs; CDKs inhibitors; Cell-cycle; Flavopiridol; Solid tumors; UCN-01.

MeSH terms

  • Cell Cycle
  • Cell Cycle Proteins*
  • Cyclin-Dependent Kinases
  • Cyclins
  • Humans
  • Neoplasms* / drug therapy
  • Neoplasms* / genetics
  • Neoplasms* / metabolism

Substances

  • Cell Cycle Proteins
  • Cyclin-Dependent Kinases
  • Cyclins